WuXi Vaccines, a global vaccine CDMO, has successfully passed an on-site GMP audit by a global vaccine company at its first standalone CDMO site in Suzhou, China. The audit marks WuXi Vaccines’ first official client conducted GMP audit of the company’s quality system, meeting GMP standards and industry benchmarks. The three-day audit covered the site’s drug substance (DS) facility, drug product (DP) facility, QC laboratories, warehouse, and utilities, as well as the quality ...